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Purpose: To determine the histologic and cellular correlates in the retina and retinal pigment epithelium (RPE)
with the presence of optical coherence tomography-deﬁned reticular pseudodrusen (RPD).
Design: Observation case using immunocytochemistry of an exenterated eye with immediate ﬁxation after
removal.
Participants: Two patients, one with conﬁrmed RPD and the other with mid-peripheral drusen, underwent
multimethod imaging before exenteration and immediate ﬁxation of the posterior eyecup for high-resolution
immunocytochemical analysis.
Methods: Optical coherence tomography (OCT) was compared with high-resolution immunocytochemistry
using a range of cellular markers to determine changes in the RPE, photoreceptors, and gliosis.
Main Outcome Measures: Correlations of the appearance of reticular pseudodrusen on OCT and immu-
nocytochemical analysis.
Results: Reticular pseudodrusen were deposits juxtaposed to photoreceptor outer segments extending
through the outer nuclear layer and even beyond the outer limiting membrane. Deposits were rich in vitronectin,
photoreceptor-associated proteins, and Iba1-immunoreactive immune cells. In contrast to conventional drusen
the lipid stain Oil Red O failed to stain RPD. Cellular analysis revealed that RPD were associated with photore-
ceptor disruption and loss and localized gliosis. In addition, anomalies in the RPE were observed.
Conclusions: Reticular pseudodrusen represent subretinal deposits that extend through the outer nuclear layer,
affect photoreceptor integrity, andareassociatedwith retinal gliosis andRPEdamage.Ophthalmology2016;123:1320-
1331 ª 2016 by the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Supplemental video is available at www.aaojournal.org.Drusen are a well-described biomarker of the early stages
of age-related macular degeneration (AMD).1 Reticular
pseudodrusen (RPD) are a relatively recently described
anomaly that have been associated with increasing risk
of late AMD, especially geographic atrophy.2e6 They
commonly appear as discrete yellow-white dots scattered
across the perifoveal region on color imaging and that have a
characteristic target-like appearance on infrared imaging.7 In
addition, in some patients, RPD manifest as interconnected
ribbons of material in the perifoveal region, or alternatively
as small lesions scattered in more peripheral retinal regions.7
Considerable debate remains about the nature of these
lesions and their cause.
The cause of RPD remains controversial. Based on en
face optical coherence tomography (OCT) and histopatho-
logic analysis, RPD have been attributed to anatomic vari-
ations within the choroidal vasculature and loss of the
middle choroidal layer in particular.3,8e10 In contrast,
dysfunction of the retinal pigment epithelium (RPE) has
been attributed to the genesis of RPD because of the sub-
retinal location of the deposits on spectral-domain (SD)
OCT and the progression to geographic atrophy.11,121320  2016 by the American Academy of Ophthalmology
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(http://creativecommons.org/licenses/by-nc-nd/4.0/). Published by Elsevier IncAlthough a great deal has been learned in recent years
using a range of imaging techniques,13 few, if any, studies
compare the histologic characteristics of retinae affected
by RPD with real-time in vivo imaging. Moreover, most
histopathologic studies performed to date have been limited
to retinae collected after death with variable ﬁxational ar-
tefacts (e.g., approximately 3 hours14 and 2 hours 40
minutes11). The potential for postmortem artifacts to affect
the interpretation of the histologic studies has led to a lack
of consensus on the ﬁndings to date. A detailed analysis
of the changes that occur in the retina and RPE is
required to understand the possible causes of RPD and
their signiﬁcance for the progression of retinal pathologic
features.
The central aim of this study was to characterize the his-
tologic and cellular changes in the retina and RPE that
correlate with the real-time appearance of RPD as determined
on SD OCT. Our results show that in a human eye imme-
diately ﬁxed after exenteration, RPD are located within the
outer nuclear layer and occur in regions where there are
RPE disruption, localized photoreceptor anomalies, and
localized retinal stress. In addition, using a range of.
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photoreceptor outer segment proteins and immune cells and
lacked labeling for lipids. These results highlight the differ-
ences between RPD and conventional drusen and suggest that
RPE dysfunction is associated with the presence of RPD.
Methods
Human Subjects and Tissue Collection
The macular research group at the Centre for Eye Research
Australia and the Oculoplastic Unit at the Royal Victorian Eye
and Ear Hospital have an ongoing collaboration to identify pa-
tients who require their eye to be removed as part of their cancer
treatment. After identifying an eligible eye, the macular re-
searchers approach the patient to request permission to examine
their eye for research purposes after its removal. Eyes identiﬁed
through this collaboration underwent laser treatment with a
nanosecond laser because of our interest in determining the tissue
response and method of action of these lasers; the results of that
investigation have already been published.15 Laser treatment was
applied 5 days before exenteration. The ﬁrst patient identiﬁed
and approached to request permission for us to apply laser
treatment to her eye in 2013 serendipitously had retinae with
extensive RPD. In 2014, a second patient was identiﬁed who
was matched in age to the ﬁrst patient, but who did not have
RPD, and underwent nanosecond laser treatment to her eye
before exenteration and served as a control for the RPD eye.
Retinal regions far removed from the lasered regions were
evaluated in this study. All procedures and protocols adhered
to the tenets of the Declaration of Helsinki and were approved
by the Human Ethics Committee of the Royal Victorian Eye
and Ear Hospital, Melbourne, Australia. Written informed
consent was obtained from both patients after the nature and
possible consequences of the study were explained.
Patient 1 was an 86-year-old white woman with a strong
family history of AMD: both her parents and sister were diag-
nosed with AMD, although she had never been. Apart from
asthma, she had no systemic illnesses. Her only medications were
aspirin 100 mg daily and nonsteroidal inhalers for asthma. In
September 2013, she was diagnosed with a high-grade, poorly
differentiated right lower lid sebaceous cell carcinoma that
required exenteration because she had undergone multiple pre-
vious resections of a lid tumor. Just before her operation, her
best-corrected visual acuity was 20/30 in both eyes. On dilated
fundus examination, she had widespread RPD throughout the
macula and above the arcades in both retinae, seen clinically and
conﬁrmed on imaging. There were fewer than 10 small (<63 mm)
drusen visible in either eye.
Patient 2 was an 86-year-old white woman with a history of
rheumatic heart disease, hypertension, and hypercholesterolemia
who underwent aortic valve replacement in 2002. She was in atrial
ﬁbrillation and was taking digoxin, warfarin, and aspirin (100 mg
daily) as well as atorvastatin (40 mg daily) for hypercholesterole-
mia. Her ocular history included herpetic scarring of the right
cornea and several operations on her right lower lid for chronic
entropion and trichiasis since 2002. In 2014, she required an
exenteration of her right eye for an aggressive sclerosing basal cell
carcinoma of her right lower lid extending into her orbit, restricting
her eye movements, and causing globe displacement and diplopia.
Just before her operation, her best-corrected visual acuity was 20/
80 in her right eye and 20/20 in her left eye. She had scattered
intermediate drusen (63e125 mm) in both eyes in the mid
periphery. There was no clinical evidence or imaging evidence
of RPD.Imaging and Image Analysis
Multimethod imaging was performed on patient 1 the day before
the exenteration, after the pupil was dilated with tropicamide 0.5%
(Mydriacyl; Alcon, Frenchs Forrest, Australia). Color fundus im-
ages were obtained using a nonmydriatic fundus camera (Canon
CR6-45NM; Canon, Saitama, Japan) and near-infrared fundus
autoﬂuorescence, and SD OCT volume scans were obtained using
a Spectralis HRAþOCT device (Heidelberg Engineering, Heidel-
berg, Germany). Scans were performed over the central 2020
area, with 49 equally spaced horizontal B-scans used. Each B-scan
contained 1024 A-scans and was set to average 25 frames each.
The grading of color fundus photographs was performed using
OptomizePro (Digital Healthcare Image Management System;
Digital Healthcare Ltd, Cambridge, United Kingdom). The pres-
ence of RPD also was determined by examination of the near-
infrared fundus autoﬂuorescence and SD OCT imaging by one of
the authors (R.H.G.). Because of media opacity in patient 2, it was
not possible to obtain high-quality images on SD OCT.
Genetics
DNA was isolated from venous blood leukocytes and 10 ng of
genomic DNA was ampliﬁed using polymerase chain reaction
analysis in a multiplex reaction using Hotstart Taq polymerase
(Bioline, London, United Kingdom). A MassEXTEND reaction
was undertaken using the designed primers, samples were spotted
onto a 384 SpectroCHIP II microarray, and genotyping was per-
formed on the MassArray platform (Sequenom, San Diego, CA).
The samples were screened for haplotype-tagging single-nucleotide
polymorphisms in complement factor H (CFH) (Y402H,
rs1061170, and rs10737680), and ARMS2 (rs10490924).16
Retinal Fixation and Immunocytochemistry
During surgery, immediately after exenteration, the eyes were
handed to the research staff, who dissected the globe, removing the
anterior contents of the eye. The posterior eyecups then were
placed into a solution containing 4% paraformaldehyde in 0.1 M
phosphate buffer (PB) for 4 hours. The time between exenteration
and ﬁxation was approximately 10 minutes. Eyecups then were
rinsed in 0.1 M PB and photographed. With visualization through a
dissecting microscope, eyecups were dissected into pieces
(approximately 4 mm2) with a scalpel blade, whereby the exact
location and eccentricity were mapped. Pieces were cryoprotected
in graded sucrose solutions (10%, 20%, 30% weight/volume),
snap-frozen, and stored at e80 C. Pieces of interest were thawed
and embedded in Tissue-Tek OCT Compound (Tissue Tek; Sakura
Finetek, Tokyo, Japan), cryosectioned (14 mm sections), and
collected on polysine glass adhesion slides (Thermo Scientiﬁc,
Scoresby, Australia). Slides were stored at e80 C until required.
Immunocytochemical labeling was performed on cryostat sec-
tions using the indirect ﬂuorescence method as described previ-
ously.17 Brieﬂy, after thawing and rinsing (3  10 minutes in 0.1 M
PB), primary antisera, diluted in a buffer containing 3% normal
goat serum, 1% bovine serum albumin (BSA), and 0.5% Triton
X-100 in 0.1 M PB, were applied to sections overnight at room
temperature. For retinal ﬂat mounts, the retina was peeled off the
RPE and incubated for 3 to 6 days free ﬂoating at 4 C. For
RPE ﬂat mounts, the choroid and attached RPE were removed
carefully from the underlying sclera. The choroiddRPE sheets
were incubated (free ﬂoating) for 3 nights at 4 C.
The primary antibodies that were used in this study included
a marker of Müller cell change, rabbit antieglial ﬁbrillary acidic
protein (GFAP; Dako, Carpinteria, CA; catalog no., Z0334; diluted
1:20,000), marker for either short-wavelength or medium- to1321
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1:100,000; kind gifts from Dr. J. Nathans), marker for cones,
peanut agglutinin-rhodamine (Vector Labs; catalog no., RL-1072;
diluted 1:250), an antibody speciﬁc to the extracellular matrix
glycoprotein vitronectin (mouse anti-vitronectin; Santa Cruz
Biotechnology; catalog no., sc-74485; diluted 1:100), a marker for
microglia and macrophages, rabbit anti-IbA1 (Wako Pure Chemi-
cal Industries, Richmond, VA; catalog no., 019-19741; diluted
1:1500), and a marker for RPE cell membranes, Alexa Fluor
633-Phalloidin (Life Technologies, Mulgrave, Australia; diluted
1:200). After incubation and rinsing in 0.1 M PB, the appropriate
goateantirabbit or goateantimouse Alexa Fluor 488 or 594 sec-
ondary antibody (Life Technologies) was applied at 1:500 dilution
together with the nuclear stain BisBenzimide H (0.1 mg/ml; Sigma
Aldrich, Castle Hill, Australia; catalog no., 14530) for 1 hour.
Slides then were rinsed in 0.1 M PB and cover slipped with
mounting medium (Dako).
Retinal and RPEechoroid ﬂat mounts were washed in PB and
mounted on slides using ﬁne brushes. Spacer rings (100 mm thick)
made from rubber tubing were placed around the mounted retinal
pieces to prevent squashing of the retinal photoreceptor inner
segmenteouter segment junctions. Flat mounts were cover slipped
with mounting medium (Dako).
After dissection and mapping, some pieces of the posterior
eyecups were postﬁxed overnight in a ﬁxative containing glutar-
aldehyde (1% paraformaldehyde, 2.5% glutaraldehyde, 3% su-
crose, and 0.01% calcium chloride in 0.1 M PB; pH 7.4), washed in
0.1 M PB, and then dehydrated in methanol (75%, 85%, 95%, in
water and 100%) and acetone (100%). Tissues were embedded in
Epon resin (ProSciTech, Townsville City, Australia) that was
polymerized. Semithin sections were cut at 1 mm with a microtome
(Ultracut S; Reichert, Depew, NY). Retinal sections were stained
with 1% toluidine blue and imaged (Axioplan; Zeiss, Gottingen,
Germany).
Histochemical Labeling of Lipid with Oil Red O
To label for esteriﬁed cholesterol and other lipids, retinal sections
were labeled with the lipid marker Oil Red O (Sigma Aldrich).
Brieﬂy, cryostat sections were postﬁxed in 4% paraformaldehyde
for 15 minutes, brieﬂy rinsed in water, and rinsed in 60% iso-
propanol. They were the stained for 40 minutes in freshly prepared
Oil Red O working solution (Oil Red O 0.3% in isopropanol;
Sigma Aldrich). Then, they were washed in water and cover slip-
ped in mounting medium.
Determination of Cell Death
Cell death was detected using a terminal deoxynucleotidyl trans-
ferase dUTP nick end labeling (TUNEL) detection kit (DeadEnd
Flurometric TUNEL system no. TB235; Promega Corp., Auburn,
Australia) as previously described.18 Six vertical cryostat sections
from the macula were examined. Retinal sections were washed
in 0.85% sodium chloride for 5 minutes, rinsed in phosphate-
buffered saline (PBS) for 5 minutes, and then incubated in 0.2%
Triton-X-100 in 0.1 M PBS for 12 minutes. The retinal sections
then were washed 3 times in PBS for 5 minutes and equilibrated
using equilibration buffer (200 mM potassium cacodylate, pH 6.6;
25 mM Tris-hydrogen chloride (HCL); 0.2 mM dithiothreitol
(DTT); 0.25 mg/ml BSA; and 2.5 mM cobalt chloride) for 10
minutes. Sections were covered in reaction mix (a solution con-
taining equilibration buffer, nucleotide mix [50 mM ﬂuorescence-
12-dUTP, 100 mM dATP, 10 mM Tris-HCl, 1 mM acetic acid] and
rTdT enzyme) for 1 hour at 37 C. The reaction was stopped with a
buffer containing 0.3 M sodium chloride and 0.15 M sodium citrate
at pH 7.2, and then the sections were rinsed 3 times in PBS for 51322minutes. After TUNEL labeling, cell nuclei were counterstained
with a 32-mM solution of 7-aminoactinomycin-D and cover slipped
in mounting medium (Dako).
Microscopy and 3-Dimensional Reconstruction
Vertical sections of immunolabeled retina were viewed on either a
Meta or Pascal confocal microscope (Zeiss, Oberkochen, Ger-
many) using 20 air or 40 oil objectives and with appropriate
ﬁlters for differential visualization of the speciﬁc ﬂuorophores.
Images were collected using Zeiss LSM or Zen software (Carl
Zeiss AG, Jena, Germany) and were edited using Zeiss LSM
software. Confocal Z-series that spanned the layers of interest in
ﬂat-mounted retinae were acquired with the optimal pinhole size
(1 Airy unit), as suggested by the software.
For 3-dimensional reconstruction, labeled ﬂat-mounted pieces
of retinae were imaged as Z-stacks and reconstructed using
IMARIS software version 7.7.0 (64; Bitplane AG, Zürich,
Switzerland). Confocal Z-stacks were reconstructed into
3-dimensional images in the Surpass mode. Background noise of
each ﬂuorescent channel was minimized individually on the
Display Adjustments panel. Images were cropped to the relevant
part of the ﬁeld without altering the resolution. Three-dimensional
representations of photoreceptor outer and inner segments with
intercalating RPDs in confocal Z-stacks were created with the
Surface function. Rendered images of different magniﬁcations
were captured using the Snapshot function and exported as .tif
ﬁles.
Thickness of the outer nuclear layer (ONL) was measured in
regions immediately above the RPD and also in adjacent areas
devoid of RPD using Zeiss LSM software. Vertical sections from
the foveal retina that were labeled for vitronectin and DAPI were
measured. Ten measurements were obtained over each vitronectin-
positive RPD and adjacent vitronectin immune-negative region that
extended from the outer limiting membrane to the distal edge of the
outer plexiform layer. In total, quantiﬁcation of 50 RPD and 50
adjacent regions were used to determine whether RPD were
associated with a change in ONL thickness.
To measure retinal stress, GFAP immunolabeling of Müller
cells was quantiﬁed in retinal regions overlying RPD compared
with regions immediately adjacent.19 Using Zeiss LSM software,
the pixel intensity was measured in retinal regions overlying
RPD and compared with regions immediately adjacent. Glial
ﬁbrillary acidic protein labeling intensity in the distal inner
plexiform layer was measured in the retina overlying 50 RPD
and 50 neighboring areas.
Statistics and Analysis
A 1-way analysis of variance was used to validate statistically the
change in GFAP immunolabeling or ONL thickness in areas with
RPD compared with regions without RPD. Correlation between
RPD area and either ONL thickness or GFAP immunolabeling was
performed using a Pearson correlation. Statistical analyses and
graphs were produced using GraphPad Prism software (San Diego,
CA).
Results
Reticular pseudodrusen of the “dot” variety were seen across the
posterior pole on examination and color fundus photographs of
patient 1 and conﬁrmed on fundus autoﬂuorescence and infrared
imaging and SD OCT in the week before exenteration (Fig
1AeD).7 Only a few small (63 mm) hard drusen were observed.
The retinal fundus of patient 1 immediately after ﬁxation is shown
Figure 1. Fundus imaging. A, Color fundus photograph of the right eye of patient 1 (P1) before exenteration. Suprathreshold nanosecond laser spots are
visible along the inferior arcade. B, Autoﬂuorescent image showing characteristic reticular pseudodrusen (RPD). C, D, Red-free fundus image (C) and
corresponding optical coherence tomography image (D) showing RPD visible as subretinal conical lesions. E, Color micrograph of the retinal fundus of P1
immediately after ﬁxation. F, Color micrograph of the retinal fundus of patient 2 (P2) immediately after ﬁxation. Subtle changes are seen along the superior
arcade where the nanosecond laser was applied.
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seen clinically in the mid periphery. No RPD were seen.
Because of media opacity in patient 2, it was not possible to
obtain high-quality images on SD OCT. However, an image of
the retinal fundus immediately after ﬁxation is shown in Figure 1F.
Patient 1 was heterozygous for the complement factor H risk alleles
(rs1061170; Y402H) and rs10737680, whereas patient 2 was
heterozygous for rs1061170 but homozygous at risk for
rs10737680. Patient 1 also was homozygous for the ARMS2
(rs104909240) risk allele, whereas patient 2 was homozygous
protective for that allele.
To establish the location of RPD relative to the RPE, we ﬁrst
carefully aligned a region of retina that had been imaged with
fundus imaging and had undergone histologic analysis. As shown
in Figure 2, several characteristic RPD were visible in the SD OCT
images as white triangular lesions projecting into the subretinal
space (Fig 2A, small arrows; Fig 2B, black arrowheads). These
lesions were identiﬁed in vertical histologic sections (Fig 2C). In
particular, vitronectin stained RPD intensely and conﬁrmed the
subretinal location of these lesions and the penetration of debris
through the outer limiting membrane into the ONL (Fig 2C,
right-hand lesion) up to the outer plexiform layer. The location
and appearance of the RPD when stained corresponded exactly to
the in vivo SD OCTeimaged RPD lesions (Fig 2).
Reticular pseudodrusen have been classiﬁed into 3 stages
depending on the level of distortion and visibility of the inner
segmenteellipsoid band.20 As shown in Figure 3, vitronectin
immunolabeled a range of subretinal deposits from long, ﬂat
lesions (stage 1) to larger conical lesions that penetrated the
outer limiting membrane into the ONL (Fig 3E, stage 2; Fig 3F,
stage 3). In comparison, vitronectin also immunolabeled a small
drusen in patient 2, but this was located beneath the RPE (Fig 3C).
We examined the effect that these deposits had on photore-
ceptor outer segments. Figure 4A shows an SD OCT image of an
RPD, and Figure 4B shows a vertical section of the corresponding
region through the same RPD, triple-labeled with the cone marker
peanut agglutinin (red), vitronectin (green), and a nuclear
counterstain (blue). The RPD deposit appears to have pushed the
photoreceptor outer segments to the side. In addition, vitronectin-
immunoreactive debris is observed in the outer nuclear layer,
suggesting that the RPD have pierced the outer limiting membrane.
Figure 4C shows a 4-dimensional rendered image of an RPD
showing the relationship between the deposit and photoreceptor
outer segments (green). A 3-dimensional animation is provided in
Video 1 (available at www.aaojournal.org).
To conﬁrm that RPD had an effect on photoreceptor integrity,
we quantiﬁed the thickness of the ONL in regions that contained
RPD compared with adjacent regions that were free of RPD. This
was achieved by quantifying the thickness of the ONL in areas
coincident with vitronectin staining in the subretinal space,
compared with the thickness in regions devoid of vitronectin
immunolabeling. As shown in Figure 4D, the ONL is signiﬁcantly
thinner in regions where vitronectin-immunolabeled debris is pre-
sent in the subretinal space, compared with areas immediately
adjacent that are devoid of immunostaining (P < 0.05, unpaired t
test). We then correlated the area of the vitronectin immunolabel-
ing with the thickness of the ONL to determine whether larger RPD
have a greater impact on photoreceptor integrity than smaller RPD.
As shown in Figure 4E, there was a positive correlation between
ONL thinning and increasing RPD area (Pearson correlation,1324r2 ¼ 0.1628; P < 0.05). We also examined whether RPD were
associated with cell death by examining TUNEL labeling across
retinal sections that contained RPD. No TUNEL labeling of
photoreceptor nuclei was noted, whereas a positive control
contained many positive nuclei (an rd1 mouse model of retinal
degeneration at postnatal day 14 is known to have a high
number of TUNEL-labeled photoreceptor nuclei data not
shown).21 These results suggest that RPD affect the integrity of
overlying photoreceptors, but that any cell death that occurs is
slow.
Retinal Stress in Regions Associated with
Reticular Pseudodrusen
In view of the impact that RPD have on photoreceptor integrity, we
evaluated the inﬂuence of RPD on localized retinal stress. Under
normal circumstances, Müller cells of nonhuman mammalian
retinae only weakly express the intermediate ﬁlament GFAP19,22
(see patient 2 in Fig 5A). When the retina experiences stress,
GFAP expression increases in Müller cells.19,23 Similarly, in
diseased conditions, Müller cells in human retina are known to
increase GFAP expression.24,25 As shown in Figure 5B, there was
localized upregulation of GFAP immunoreactivity in Müller cell
processes in regions adjacent to RPDs, but little GFAP
immunolabeling of Müller cells in regions of the retina where
RPD were absent, nor in the retina of patient 2. This observation
was conﬁrmed by quantifying the pixel intensity of GFAP
immunolabeling in Müller cells within the inner plexiform layer
in regions containing RPD compared with adjacent regions that
were free of RPD (P < 0.05, unpaired t test; Fig 5D). In
addition, we correlated the area of RPD (as measured by
vitronectin labeling) with pixel intensity of GFAP labeling.
There was no signiﬁcant correlation between area of RPD and
GFAP immunolabeling. These results suggest that RPD are
associated with retinal stress as measured by GFAP
immunolabeling, but that there is no exacerbation of gliosis in
larger compared with smaller RPD.
Composition of Reticular Pseudodrusen
Conventional drusen are known to contain a large range of protein,
lipid, and other moieties.26 However, little is known about the
composition of RPD. Oil Red O has been used previously to
identify lipid constituents of conventional drusen27,28 and was
used here as a way of determining whether there were differences
in lipid composition between RPD and conventional drusen. As
shown in Figure 6A, Oil Red Oelabeled deposits were located
between the RPE and Bruch’s membrane (conventional small
drusen), but not subretinal deposits. This suggests that if there is
any lipid in RPD, then the lipid composition of RPD is distinct
from conventional drusen.
We examined whether immune cells were associated with RPD.
Iba1 is a known marker of retinal microglia and macrophages. The
subretinal deposit contained DAPI-positive nuclei, suggesting that
cells are a constituent of RPD (Fig 6B, C, C0). Moreover, double
labeling revealed that the cells within RPD are immunoreactive
for the mononuclear cell marker Iba1. This suggests that immune
cells, either microglia or macrophages, are associated with RPD.
We evaluated immunolabeling of RPD for photoreceptor proteins
and other proteins known to be found in conventional drusen.
Deposits within RPD were immunolabeled for cone opsin as
Figure 2. Coincidence of imaging and histologic results. A, High magniﬁcation of a red-free fundus image with optical coherence tomography (OCT) image
from the central fovea of patient 1 (center inset). Several reticular pseudodrusen (RPD) are indicated by the white arrows. B, Higher magniﬁcation of the
OCT image obtained from the region in (A) indicated by the dotted line. Three RPD are indicated by black arrowheads. Blood vessels are indicated by asterisks.
C, The corresponding vertical section of retina immunolabeled with vitronectin (red), glial ﬁbrillary acidic protein (green), and the nuclear stain DAPI
(blue). The 3 RPD from (B) are shown by white arrowheads. GCL ¼ ganglion cell layer; INL ¼ inner nuclear layer; IS/OS ¼ inner segmenteouter segment
junction line; ONL ¼ outer nuclear layer; RPE ¼ retinal pigment epithelium.
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prominent marker of RPD and labeled all RPD, regardless of size,
across the retina (Figs 3 and 6). Notably, vitronectin-
immunoreactive deposits varied from large, wedge-like structures
that extended into the ONL to small, ﬂat lesions located between
the photoreceptor outer segments and RPE. We also performed
immunolabeling for b-amyloid as well as a range of complement
factors and immune markers, including C3, C5a, CD11b, and
CD102, but for these markers, no labeling was detected in humanretinae from either patient, whereas control retina (mouse vertical
sections) showed positive results.
Association of Reticular Pseudodrusen with
Retinal Pigment Epithelium and Choroidal
Changes
The cause of RPD remains controversial. Two theories for the
generation of RPD have been postulated, including loss of the1325
Figure 3. Different stages of reticular pseudodrusen (RPD). Vertical sections of the retina from patient 1 (P1) and patient 2 (P2) immunolabeled with
vitronectin (green), peanut agglutinin (red), and a nuclear marker DAPI (blue). A, Low magniﬁcation of a section from the inferior macula of P1 showing
multiple vitronectin-positive subretinal deposits (white arrowheads). B, C, Vertical section of the retinal pigment epithelium (RPE) and photoreceptor outer
segments of (B) an unaffected area and (C) a region containing conventional drusen. Vitronectin intensely labels conventional drusen as well as basal
laminar deposits. DeF, Vertical sections of photoreceptor outer segments and RPE from P1 showing different grades of RPD: (D) stage 1, (E) stage 2, and
(F) stage 3. bv ¼ blood vessel; GCL ¼ ganglion cell layer; INL ¼ inner nuclear layer; ONL ¼ outer nuclear layer; OS/IS ¼ outer segmenteinner segment
junction line.
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examined the choroidal vasculature from both patients and also
evaluated the presence of vascular endothelium in regions imme-
diately beneath RPD in patient 1. Notably, the vasculature was
associated with endothelial cells in both patients, and there was no
evidence of sclerosed choroidal vessels in regions immediately
beneath RPD, suggesting that choroidal vessels remain patent
across the choroid despite the presence of RPD. Notably, there
appeared to be no differences in the structure of the choroid in
either patient.
Retinal pigment epithelium dysfunction has been suggested as a
possible contributor for debris buildup within the subretinal space.
As shown in Figure 7, vitronectin-immunoreactive RPD often were
associated with regions where RPE cells had migrated into the
subretinal space. Anomalies in RPE cells also were visible at a
higher magniﬁcation in toluidine blueestained semithin sections
(Fig 7B). Using the presence of pigment, lipofuscin, or both as a
way of identifying RPE cells, we were able to conﬁrm that Iba1-
immunoreactive cells were present in most RPDs, and migrating
RPE cells were located in areas adjacent, but not within, RPD. In
particular, no pigmented cells were noted within RPD (Fig 6A).
Phalloidin is a marker of actin ﬁlaments and labels the cellular
boundaries of RPE cells. In regions where RPD were located,
there was considerable irregularity in RPE cell size and shape,
whereas in regions devoid of RPD, the hexagonal cell shape was
more uniform. In some areas, enlarged RPE cells also were seen
(Fig 7D, insert), which could be explained by the loss of RPE
cells and a hypertrophy of neighboring cells in areas where RPD
are located.Discussion
The main ﬁndings of this study were that RPD were located
on the subretinal side of the RPE, extending up into the1326outer segment layer and through into the ONL, and were
associated with reduced photoreceptor integrity. In addition,
the RPE in areas affected by RPD were altered compared
with nonaffected areas of the RPE.
The results of this study demonstrate that RPD form
characteristic lesions of varying sizes within the subretinal
space that correspond to vitronectin-rich extracellular de-
posits. These results conﬁrm a number of imaging studies
that have suggested that RPD represent the accumulation of
hyperreﬂective material within the subretinal space.20,29
However, of the 3 types of RPD described by Suzuki
et al,7 the results of this study reﬂect the cellular detail of the
most common dot form of RPD. Additional work is needed
to identify whether ribbon or mid-peripheral RPD have
similar characteristics to the dot type.
The results of this study show that photoreceptors are
affected by the presence of RPD. In particular, the ONL was
thinner in regions where RPD were located compared with
neighboring RPD-free areas, and photoreceptors were
pushed to the side in regions immediately overlying RPD.
Our results are in agreement with those of a previous study
that used adaptive optics to show a reduction in cone density
overlying RPD compared with regions between the RPD.30
In agreement with the effects on photoreceptor integrity,
RPD were associated with localized Müller cell gliosis, an
indicator of localized retinal stress.19,23
The composition of RPD remains to be deﬁned clearly. A
previous study suggested that subretinal drusenoid deposits
and conventional drusen share many similarities in
composition, including unesteriﬁed cholesterol, vitronectin,
and complement factors, including complement factor
H.11,26 In contrast, subretinal drusenoid deposits did not
label for photoreceptor-associated proteins in that study.
Using immunocytochemical labeling, we found that RPD
were associated with immune cells, Iba1-immunoreactive
Figure 4. High magniﬁcation of reticular pseudodrusen (RPD). A, Optical coherence tomography image of an RPD in patient 1. B, Corresponding vertical
section of the same RPD immunolabeled for vitronectin (green), peanut agglutinin (red), and nuclear stain DAPI (blue). C, Three-dimensional image of an
RPD in the subretinal space. A deposit is visible between the outer segments of the cones. D, E, Changes in thickness of the outer nuclear layer (ONL) with
RPD.D, Graph showing the mean plus standard error of the mean ONL thickness in regions overlying RPD and adjacent nonaffected areas. Regions without
RPD showed a statistically signiﬁcantly thicker ONL (P < 0.05). E, Correlation between ONL thickness and RPD area. GCL ¼ ganglion cell layer;
HF ¼ Henle Fiber layer; INL ¼ inner nuclear layer; IPL ¼ inner plexiform layer; IS ¼ inner segment; OS ¼ outer segment; RPE ¼ retinal pigment
epithelium.
Greferath et al  Characterization of Reticular Pseudodrusenmicroglia and macrophages, as well as photoreceptor pig-
ments, including opsins and peanut agglutinin. In addition,
vitronectin, a plasma protein, was a prominent feature of
RPD. In contrast to conventional drusen, the lipid stain Oil
Red O failed to label RPD, suggesting that lipid composition
is distinct between the 2 types of drusen. The differences in
this and the previous study could be explained by the ﬁx-
ation protocols and postmortem time, which inﬂuence the
intensity of immunolabeling. Alternatively, there may be
subtle variations in the composition of different types of
extracellular deposits or among different patients.
Our results highlight that the RPE is affected in areas
where RPD are located. The RPE is known to play a critical
role in maintaining the integrity of photoreceptors, playing a
crucial role in outer segment phagocytosis and the recycling
of retinoids.31 It is possible that localized dysfunction or lossof RPE cells could lead to the observed accumulation of
photoreceptor outer segment debris in discrete areas.
Indeed, loss of RPE cells in a transgenic mouse model of
conditional RPE loss was associated with localized
accumulation of debris within the subretinal space as well
as migration of individual RPE cells into the retina.32 In
addition, mutations in mer Tyrosine kinase, which is
known to be vital for outer segment phagocytosis by RPE,
are associated with photoreceptor debris accumulation in a
similar location around photoreceptor outer segments and
subsequent photoreceptor degeneration in rodent models
of inherited retinal degeneration.21
There are several limitations of this study. Notably, only
1 eye from a patient with RPD was analyzed in this study.
However, the ﬁxation was rapid, occurring immediately
after exenteration, minimizing any tissue effects that can1327
Figure 5. Localized gliosis and reticular pseudodrusen (RPD). A, Vertical section of retina immunolabeled for glial ﬁbrillary acidic protein (GFAP; red) and
vitronectin (green). In patient 2 (P2), GFAP labeling is concentrated at the nerve ﬁber layer (NFL) of the retina. B, C, Increased GFAP labeling is observed
(B) in the region below a vitronectin-positive RPD in patient 1 (P1; small arrow), but (C) not outside the area. D, Graph showing the mean plus standard
error of the mean GFAP pixel intensity in regions overlying RPD and adjacent nonaffected areas. Regions without RPD showed a statistically signiﬁcant
lower GFAP staining intensity (P < 0.02). E, Correlation between GFAP pixel intensity and RPD area. bv ¼ blood vessel; INL ¼ inner nuclear layer;
ONL ¼ outer nuclear layer.
Ophthalmology Volume 123, Number 6, June 2016occur because of postmortem time and that may have
limited interpretation of previous histopathologic studies.
The composition of the RPD was performed by immuno-
cytochemical analysis. Our patient had virtually no typical
drusen, whereas most eyes with RPD seen in a clinic setting
have conventional drusen as well. The lack of drusen may
provide a more distinct RPD phenotype than that which
would be seen in the presence of multiple drusen, and as
such our ﬁndings may be typical only of RPD without the
presence of drusen. A far more complete list of RPD con-
stituents is possible with unbiased gene or proteomic1328methods.33 More work with more samples is required to
establish the composition of RPD.
In conclusion, using human retinae that had been ﬁxed
immediately after exenteration, we established that RPD are
subretinal deposits, extending into the outer segment and
inner nuclear layer. Reticular pseudodrusen are associated
with localized photoreceptor disruption and retinal stress. In
addition, our results show that the RPE is abnormal in re-
gions of the retina with RPD. These results highlight that
RPD are a distinct type of deposit compared with conven-
tional drusen and may be associated with RPE dysfunction.
Figure 6. Composition of reticular pseudodrusen (RPD). A, Region of distal retinaeretinal pigment epithelium (RPE) from patient 1 labeled with Oil Red
O. A conventional drusen indicated by the black arrow is labeled. In contrast, an RPD in close proximity (arrowhead) is unlabeled by Oil Red O. BeC0,
Vertical section through an RPD immunolabeled for IbA1 (green) and DAPI (blue) showing IbA1-positive microglia and macrophages (arrows). D, Reticular
pseudodrusen immunolabeled for a combination of S and L/M cone opsins (green) and DAPI (blue). E, Reticular pseudodrusen immunolabeled for
vitronectin (green) and DAPI (blue). INL ¼ inner nuclear layer; IS/OS ¼ inner segmenteouter segment junction line; ONL ¼ outer nuclear layer.
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Figure 7. Anomalies in retinal pigment epithelium (RPE) and reticular pseudodrusen (RPD). A, Vertical section through an RPD region of patient 1 (P1)
stained for glial ﬁbrillary acidic protein (red) and vitronectin (green). Some autoﬂuorescent RPE aberrantly invade the outer segment area of the photo-
receptors (arrowheads). B, Semithin section through an RPD region of P1 stained with toluidine blue showing RPE cells aberrantly displaced toward the
retina. CeE, Flat mounts of RPE stained for phalloidin (green) labeling the cellular boundaries of RPE cells: (C) ﬂat mount of patient 2 (P2), (D) RPD area
of P1, (E) outside of RPD area in P1. In regions where RPD are located, there is considerable irregularity in RPE cell size and shape, whereas in regions
devoid of RPD, the hexagonal cell shape was more uniform. GCL ¼ ganglion cell layer; INL ¼ inner nuclear layer; ONL ¼ outer nuclear layer.
Ophthalmology Volume 123, Number 6, June 2016Further work is necessary to understand more clearly the
cause of RPD and their association with late AMD.
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